Related references
Note: Only part of the references are listed.Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor
T. J. N. Hiltermann et al.
ANNALS OF ONCOLOGY (2012)
Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer
Jian-Mei Hou et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse
Emmanouil Saloustros et al.
BREAST CANCER RESEARCH (2011)
Survival and prognostic factors in small cell lung cancer
Jian Li et al.
MEDICAL ONCOLOGY (2010)
SCG3 Transcript in Peripheral Blood Is a Prognostic Biomarker for REST-Deficient Small Cell Lung Cancer
Adrian C. Moss et al.
CLINICAL CANCER RESEARCH (2009)
Cytokeratin-19 mRNA-Positive Circulating Tumor Cells After Adjuvant Chemotherapy in Patients With Early Breast Cancer
Nikolaos Xenidis et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Circulating tumor cells and bone marrow micrometastasis
Catherine Alix-Panabieres et al.
CLINICAL CANCER RESEARCH (2008)
Prognostic and predictive value of vascular endothelial growth factor and its soluble receptors, VEGFR-1 and VEGFR-2 levels in the sera of small cell lung cancer patients
Zeki Ustuner et al.
MEDICAL ONCOLOGY (2008)
CK19 mRNA expression measured by reverse-transcription polymerase chain reaction (RT-PCR) in the peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation: An independent prognostic factor
Ting-Feng Chen et al.
LUNG CANCER (2007)
Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer:: A validation study of the CellSearch system
Sabine Riethdorf et al.
CLINICAL CANCER RESEARCH (2007)
Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients
Nikos Xenidis et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Observation of circulating tumour cells in patients with non-small cell lung cancer by real-time fluorescent quantitative reverse transcriptase-polymerase chain reaction in peroperative period
MJ Ge et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2006)
REporting recommendations for tumour MARKer prognostic studies (REMARK)
LM McShane et al.
EUROPEAN JOURNAL OF CANCER (2005)
Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques
AE Ring et al.
BRITISH JOURNAL OF CANCER (2005)
Recent advances in management of small-cell lung cancer
YJ Chua et al.
CANCER TREATMENT REVIEWS (2004)
The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up
RM Bremnes et al.
LUNG CANCER (2003)
Prognostic value of serum tumor markers in patients with lung cancer
KD Hatzakis et al.
RESPIRATION (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC)
T Shibayama et al.
LUNG CANCER (2001)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)